Fossil to be added to S&P 500; Medco Health deleted on date TBA S&P 500 constituent Express Scripts (ESRX) is acquiring Medco Health Solutions (MHS) in a deal expected to be completed soon pending final approvals.
Fossil downgraded to Neutral from Overweight at Piper Jaffray Piper Jaffray downgraded Fossil to Neutral saying the company's North American growth could slow further while foreign currency is a headwind with a third of its sales coming from Europe. Piper lowered its price target for shares to $104 from $133.
Express Scripts CEO says Gilead relationship 'important' going forward Express Scripts (ESRX) CEO George Paz at the J.P. Morgan Healthcare Conference said his company's relationship with Gilead (GILD) is "important" going forward. Paz said his company's goal is not to exclude drugs. He continues to discuss Express Scripts's deal with AbbVie (ABBV) and the company's goal of saving clients money with regards to healthcare costs.